What this means
This is a registered study plan that is still recruiting people. It has not reported any results yet, so it does not show what the treatment does.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 13 and over
- Where
- 1 site, including Connecticut
The science
- Registered title
- The Impact of Phosphate Metabolism on Healthy Aging
- Trial ID
- NCT03771105 ↗
- Phase
- EARLY PHASE 1
- Study type
- interventional
- Conditions
- Hypophosphatemia, Rickets, Hypercalciuria, XLH, HHRH
- What is tested
- phosphate
- Sponsor
- Yale University
- Ages
- 13 Years to no maximum
- Dates
- First posted Dec 10, 2018 · updated May 27, 2026
Registry summary
Determine the association between duration and dose of chronic conventional therapy with Pi and renal (nephrocalcinosis/nephrolithiasis), vascular (endothelial function), and cardiovascular function (echo- cardiography) in patients with hereditary hypophosphatemic rickets with hypercalciuria (HHRH) and patients with X-linked hypophosphatemia (XLH).
Sites (1)
- Yale University School of Medicine, New Haven, Connecticut, United States